Average Co-Inventor Count = 4.09
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nestec S.a. (6 from 2,370 patents)
2. Societe Des Produits Nestle S.a. (6 from 1,150 patents)
3. Pierian Holdings, Inc. (3 from 3 patents)
4. Prometheus Laboratories Inc. (1 from 22 patents)
5. Diatech Holdings, Inc. (1 from 1 patent)
17 patents:
1. 10697967 - Methods for predicting response of triple-negative breast cancer to therapy
2. 10640830 - Drug selection for non-small cell lung cancer therapy
3. 10527622 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells
4. 10473640 - Drug selection for gastric cancer therapy using antibody-based arrays
5. 10436786 - Methods for detecting truncated receptors using antibody-based arrays
6. 10401364 - Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling
7. 9903867 - Methods for predicting and improving the survival of colorectal cancer patients
8. 9726669 - Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy
9. 9719995 - Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling
10. 9664683 - Profiling of signal pathway proteins to determine therapeutic efficacy
11. 9575066 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells
12. 9488654 - Methods for predicting response of triple-negative breast cancer to therapy
13. 9285369 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells
14. 9274116 - Drug selection for breast cancer therapy using antibody-based arrays
15. 8658388 - Antibody-based arrays for detecting multiple signal transducers in rate circulating cells